Jacob Grønnegaard of FujiFilm Diosynth Biotechnologies discussed how the company’s unique cloning processes dramatically reduce project execution time, effort and expense at Emerson Exchange Immerse event. The result is intended to be one of the top medicine production facilities in the country. Hopefully, it won’t have to ramp up production for a virus vaccine to combat a worldwide pandemic, but if the time ever comes again, it will be scalable and ready.
Latest News
Emerson Appoints Michael Tang as Chief Legal Officer
Emerson today announced the appointment of Michael Tang as senior vice president, secretary and chief legal officer. Tang succeeds Sara Yang...
Emerson to Share Sustainability Progress, Spotlight Innovations at COP28
Global automation software and technology company Emerson will lend its voice and proven expertise to vital conversations at the 2023 United...
DG Fuels Selects Emerson Engineering and Automation Portfolio to Support Sustainable...
DG Fuels Selects Emerson to Support Sustainable Biofuels Production
